IBB News and Press, iShares Biotechnology ETF From 09/22/23

2023-09-22 03:30:00 ET Summary Healthcare stocks often serve as powerful painkillers during market declines. While the MSCI World Index fell by 18.1% in 2022, healthcare stocks fell by only 5.4%. Investing effectively in healthcare stocks requires a unique set of skills. ...

2023-09-19 14:45:33 ET Summary Regeneron Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Tarrytown that has played a key role in the fight against COVID-19. Regeneron's revenue for the second quarter of 2023 was $3.16 billion, an increase of 10.5% compared to th...

2023-09-14 13:17:43 ET Summary US sectoral flows for August 2023 show a negative result, with a fall in financial balances in the domestic private sector. The chart suggests that the SPX's next move would be for lower markets heading into September. Fiscally September is norma...

2023-09-09 03:17:14 ET Summary Wall Street underestimates the prospects of Pfizer and Gilead Sciences, given their significant role in developing vaccines and medicines against COVID-19. Gilead Sciences' revenue has remained stable in recent quarters, unlike Pfizer, whose demand f...

2023-09-08 21:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-09-08 00:03:09 ET Summary The recent IRA list of 10 drug publications is not expected to have a significant impact on big pharma stocks in the near term. The legal challenges by big pharma companies against the IRA may derail the implementation of the drug pricing reforms. ...

2023-08-30 12:47:05 ET Summary The biotechnology sector has disappointed overall; we think there are better ways to get exposure to the healthcare sector. iShares Biotechnology ETF has underperformed relative to Health Care Select Sector SPDR® Fund ETF. Investing in a bro...

2023-08-30 07:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-08-19 13:10:24 ET Summary NewAmsterdam Pharma showcased positive trajectory in Q2 2023 financial report, with over-enrollment in obicetrapib's Ph.3 BROADWAY trial indicating robust global demand. Lead asset obicetrapib is set to present top-line data in 2H24, with potential a...

2023-08-18 13:09:45 ET Summary On August 7, Viatris released its financial results for the 2nd quarter of 2023, which, after a long time, finally managed to beat analysts' expectations. Viatris' revenue for the second quarter of 2023 was $3.92 billion, up 5.1% from the previous qu...